Literature DB >> 28124114

Activation of ventral tegmental area dopamine neurons produces wakefulness through dopamine D2-like receptors in mice.

Yo Oishi1, Yoshiaki Suzuki2, Koji Takahashi2, Toshiya Yonezawa2, Takeshi Kanda2, Yohko Takata2, Yoan Cherasse2, Michael Lazarus3.   

Abstract

A growing body of evidence suggests that dopamine plays a role in sleep-wake regulation, but the dopamine-producing brain areas that control sleep-wake states are unclear. In this study, we chemogenetically activated dopamine neurons in the ventral midbrain of mice to examine the role of these neurons in sleep-wake regulation. We found that activation of dopamine neurons in the ventral tegmental area (VTA), but not in the substantia nigra, strongly induced wakefulness, although both cell populations expressed the neuronal activity marker c-Fos after chemogenetic stimulation. Analysis of the pattern of behavioral states revealed that VTA activation increased the duration of wakefulness and decreased the number of wakefulness episodes, indicating that wakefulness was consolidated by VTA activation. The increased wakefulness evoked by VTA activation was completely abolished by pretreatment with the dopamine D2/D3 receptor antagonist raclopride, but not by the D1 receptor antagonist SCH23390. These findings indicate that the activation of VTA dopamine neurons promotes wakefulness via D2/D3 receptors.

Entities:  

Keywords:  Chemogenetics; D1 receptors; DAT-Cre mice; Midbrain; Sleep; Substantia nigra

Mesh:

Substances:

Year:  2017        PMID: 28124114     DOI: 10.1007/s00429-017-1365-7

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  35 in total

1.  Nigrostriatal and mesolimbic control of sleep-wake behavior in rat.

Authors:  Mei-Hong Qiu; Zhi-Gang Zhong; Michael C Chen; Jun Lu
Journal:  Brain Struct Funct       Date:  2019-07-19       Impact factor: 3.270

2.  The neuroanatomy and neurochemistry of sleep-wake control.

Authors:  Heinrich S Gompf; Christelle Anaclet
Journal:  Curr Opin Physiol       Date:  2019-12-31

3.  Activation of Dopamine Signals in the Olfactory Tubercle Facilitates Emergence from Isoflurane Anesthesia in Mice.

Authors:  Bo Yang; Yawen Ao; Ying Liu; Xuefen Zhang; Ying Li; Fengru Tang; Haibo Xu
Journal:  Neurochem Res       Date:  2021-03-12       Impact factor: 3.996

Review 4.  Neuronal Mechanisms for Sleep/Wake Regulation and Modulatory Drive.

Authors:  Ada Eban-Rothschild; Lior Appelbaum; Luis de Lecea
Journal:  Neuropsychopharmacology       Date:  2017-12-05       Impact factor: 7.853

Review 5.  Newly identified sleep-wake and circadian circuits as potential therapeutic targets.

Authors:  Anne Venner; William D Todd; Jimmy Fraigne; Hannah Bowrey; Ada Eban-Rothschild; Satvinder Kaur; Christelle Anaclet
Journal:  Sleep       Date:  2019-05-01       Impact factor: 5.849

6.  The Arousal-motor Hypothesis of Dopamine Function: Evidence that Dopamine Facilitates Reward Seeking in Part by Maintaining Arousal.

Authors:  Marcin Kaźmierczak; Saleem M Nicola
Journal:  Neuroscience       Date:  2022-07-16       Impact factor: 3.708

7.  The molecular genetics of human sleep.

Authors:  Luoying Zhang; Ying-Hui Fu
Journal:  Eur J Neurosci       Date:  2018-09-20       Impact factor: 3.386

8.  Sleep and Wakefulness Are Controlled by Ventral Medial Midbrain/Pons GABAergic Neurons in Mice.

Authors:  Yohko Takata; Yo Oishi; Xu-Zhao Zhou; Emi Hasegawa; Koji Takahashi; Yoan Cherasse; Takeshi Sakurai; Michael Lazarus
Journal:  J Neurosci       Date:  2018-10-03       Impact factor: 6.167

9.  Dopaminergic modulation of human consciousness via default mode network connectivity.

Authors:  Brian L Edlow
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

Review 10.  The Neural Circuits Underlying General Anesthesia and Sleep.

Authors:  Olivia A Moody; Edlyn R Zhang; Kathleen F Vincent; Risako Kato; Eric D Melonakos; Christa J Nehs; Ken Solt
Journal:  Anesth Analg       Date:  2021-05-01       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.